Testolactone

睾内酯

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTestolactone
Drug Alias Name睾内脂testolactonetestolactonum睾内酪testolactona +[11
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAromatase inhibitors
TargetsAromatase
Therapy Area/IndicationsPuberty, PrecociousFibrous Dysplasia, PolyostoticBreast Neoplasms
Global Approved IndicationsBreast Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1969/06/03
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPuberty, PrecociousFibrous Dysplasia, PolyostoticBreast Neoplasms

Other Information

ATC CodeN/A